Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected
- PMID: 10522067
Lymph node involvement rate in low-grade gastric mucosa-associated lymphoid tissue lymphoma--too high to be neglected
Abstract
Background/aims: Anti-Helicobacter pylori (H. pylori) treatment for low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma has been the subject of attention. The aim of this study was to determine the proportion of such cases which could be suitable candidates for H. pylori eradication for the purpose of cure; we focused on gross morphology and lymph node metastasis.
Methodology: We retrospectively reviewed the medical records of 53 patients diagnosed and treated for gastric MALT lymphoma at Seoul National University Hospital between 1992 and 1996.
Results: According to Isaacson's classification, 60% of cases were low-grade, and H. pylori was detected in 88% of them. In low-grade disease, gastroscopy revealed superficial lesions in 56% of cases, ulcerofungating lesions were found in as much as 19%, and ulceroinfiltrating in 25%. Even in low-grade disease, invasion of proper muscle, or deeper, was seen in 28% of patients, and lymph node involvement in 36%; even in low-grade disease confined to mucosa and submucosa, the rate of lymph node involvement was 40%. All cases which, on gastroscopy, appeared to be gastritis or benign ulcer-like lesions were free of lymph node metastasis, but in low-grade disease, this proportion was only 16%. In 33% of cases, pre-operative clinical stage I--as shown by abdominal CT--was found post-operatively to be stage II. The negative predictive value of lymph node detection by CT was 68%.
Conclusions: In low-grade gastric MALT lymphoma, the lymph node involvement rate was too high to be neglected. In detecting lymph node metastasis, the diagnostic accuracy of CT was too low. The proportion of suitable candidates for anti-H. pylori treatment for low-grade gastric MALT lymphoma was not high, and in clinical practice, anti-H. pylori treatment in such cases should at present be very carefully applied.
Similar articles
-
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.J Med Invest. 2000 Feb;47(1-2):36-46. J Med Invest. 2000. PMID: 10740978
-
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.J Natl Cancer Inst. 2005 Sep 21;97(18):1345-53. doi: 10.1093/jnci/dji277. J Natl Cancer Inst. 2005. PMID: 16174856
-
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.Am J Gastroenterol. 2002 Feb;97(2):292-7. doi: 10.1111/j.1572-0241.2002.05460.x. Am J Gastroenterol. 2002. PMID: 11866264 Clinical Trial.
-
Gastric mucosa-associated lymphoid tissue lymphoma.Am J Gastroenterol. 2003 May;98(5):975-86. doi: 10.1111/j.1572-0241.2003.07424.x. Am J Gastroenterol. 2003. PMID: 12809817 Review.
-
Helicobacter pylori strikes again: gastric mucosa-associated lymphoid tissue (MALT) lymphoma.Gastroenterol Nurs. 2007 Sep-Oct;30(5):348-54; quiz 355-6. doi: 10.1097/01.SGA.0000296255.16576.e5. Gastroenterol Nurs. 2007. PMID: 18049205 Review.
Cited by
-
Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.Gut. 2006 Jun;55(6):886-93. doi: 10.1136/gut.2004.061663. Gut. 2006. PMID: 16698756 Free PMC article. Review. No abstract available.
-
Mucosa-associated lymphoid tissue lymphomas.Curr Oncol Rep. 2000 Mar;2(2):192-8. doi: 10.1007/s11912-000-0093-x. Curr Oncol Rep. 2000. PMID: 11122843 Review.
-
Clinicopathologic features of surgically resected primary gastric lymphoma.World J Gastroenterol. 2004 Apr 15;10(8):1103-9. doi: 10.3748/wjg.v10.i8.1103. World J Gastroenterol. 2004. PMID: 15069707 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical